Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Amylin Pharmaceuticals

Founders Howard (Ted) Greene

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 2
Rounds per year 0.06
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
Summary

Amylin Pharmaceuticals is the famous Corporate Investor, which was founded in 1987. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the San Diego.

The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2009. The high activity for fund was in 2007. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 2 participants. Despite the Amylin Pharmaceuticals, startups are often financed by QIC BioVentures. The meaningful sponsors for the fund in investment in the same round are QIC BioVentures, Innovis Investments. In the next rounds fund is usually obtained by GBS Ventures, QIC BioVentures.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Xenome, BioSeek. We can highlight the next thriving fund investment areas, such as Medical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Amylin Pharmaceuticals:
Typical Co-investors
Amylin Pharmaceuticals is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Amylin Pharmaceuticals:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CCC Marketing Japan, Tokyo
Economic Development of the Longueuil Conurbation Boucherville, Canada, Quebec
Forum Media Group Bavaria, Germany, Merching
Franklin Square Group District of Columbia, United States, Washington
Global Excel Management Inc. Canada, Quebec, Sherbrooke
Invitation Homes Dallas, Texas, United States
Jayant Group Bilaspur, Chhattisgarh, India
Manipal Hospitals Bangalore, India, Karnataka
Media Future Japan, Tokyo
NKB Baden-Wurttemberg, Binswangen, Germany
NY Group Partners -
Prestige Angel Beijing, Beijing, China
Riordan, Lewis & Haden Equity Partners California, Los Angeles, United States
Signet Enterprises Akron, Ohio, United States
Solis Capital Partners California, Newport Beach, United States
The Provco Group Bryn Mawr, Pennsylvania, United States
Times Bridge California, Redwood City, United States
University of Melbourne Australia, Melbourne, Victoria
Venture Capital Guiding Fund of Songjiang China, Shanghai
Willfly Ventures India, Maharashtra, Mumbai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biopharma
Biotechnology
Medical
Therapeutics
$10M27 Nov 2007 Queensland

BioSeek

Biotechnology
$10M23 May 2007 South San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Amylin Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: